May 15, 2026
avatar-torie-bosch
First Opinion editor

On the “First Opinion Podcast” this week, I spoke with Eric Topol and Shelley Wood about their recent STAT piece on 25 years of blue zones: geographically isolated places where, according to some, the local population live much longer than expected. Topol and Wood looked at the science and profit-making around blue zones and concluded that in many ways, they aren’t real. For instance, as they point out, the first blue zones were found in small villages in Sardinia, where many birth records had been destroyed during World War II. There’s also a profit motive in some of the continued blue zone chatter.

Nevertheless, many blue zone concepts — and the Netflix documentary that brought it back to the fore — are worthwhile, they said: a healthy diet, clean air, community and family connection, exercise.

They also answered my most pressing question: Why are the zones blue instead of another color? You’ll have to listen to find out.

Recommendation of the week: I haven’t yet finished it, but I’m going to take a chance and recommend “The Bewitching,“ by Silvia Moreno-Garcia, author of “Mexican Gothic.” “The Bewitching,” which I wish I were reading right now, bounces between Mexico and New England across the 1900s, 1930s, and 1990s to tell a story of witches, folklore, and family.



Health workers walk with a boy suspected of having Ebola in eastern Congo in September 2018.
AP Photo/Al-hadji Kudra Maliro, File

First hantavirus, now Ebola: What two outbreaks reveal about global preparedness

Outbreaks like Ebola and hantavirus are becoming more frequent, more complex, and increasingly difficult to contain.

By Krutika Kuppalli


Telehealth abortion with mifepristone continues, with backup plans still in place

Regardless of the mifepristone case’s ultimate outcome, safe and effective medication abortion, including via telehealth, isn’t going away.

By Christine Henneberg


I’m 73. I wish my pills wouldn’t keep changing colors and shapes

The constant changing of pills’ shapes and colors — often caused by switching generic manufacturers — leads to confusion, especially for seniors.

By Barbara Wolf


Craig Venter, then-President Bill Clinton, and Francis Collins of the National Institutes of Health talk about mapping the human genetic code on June 26, 2000, at the White House.
Mark Wilson/Newsmakers via Getty Images

Tributes to Craig Venter and the genomics race are missing something important

Honoring Craig Venter’s legacy as a genomics legend doesn’t require flattening the story of decoding the human genome.

By Zachary Utz


Using AI in addiction medicine could be particularly risky

There is a role for AI in medicine. But in addiction medicine, ‘empathetic’-seeming AI agents could be very risky.

By Steve D. Klein


The hantavirus is a wake-up call. Will the Trump administration answer it?

Hantavirus will fade from the public eye. But the gaps this outbreak revealed in our ability to respond will remain.

By Craig Spencer


Online tools exist to fact-check health claims such as a TikTok on the benefits of onion water for treating the flu.
OLIVIER DOULIERY/AFP via Getty Images

Hospitals are silencing doctors online, and it’s fueling the health misinformation crisis

Fear of employer consequences is one of the primary reasons physicians pull back from public engagement online.

By Adam Goodcoff


Access to air conditioning is critical preventive care. But federal policy treats it as optional

Heat-related deaths will continue to rise, especially among people managing a chronic disease without reliable access to air conditioning.

By Charles E. Leonard and Anthony Nicome


What can ‘blue zones’ really teach us about aging?

How real are blue zones? Cardiologist Eric Topol and medical journalist Shelley Wood weigh in on the concept 25 years after it originated.

By Torie Bosch


Adobe

RFK Jr.’s antidepressant deprescribing push gets one thing right — and others dangerously wrong

Deprescribing SSRIs is a dynamic, individualized process that requires ongoing clinical judgment — not a one-time decision.

By Jonathan Slater


STAT+ | Pharma and biotech leaders are destroying their own industry

With their focus on China, American biotech leaders are prioritizing short-term profits over the long-term stability of the industry.

By Olivia Kosloff


What addiction medicine can teach us about depending on AI

When people hear the word “addiction,” they often assume it implies catastrophe. But it starts with the gradual shift from optional use to psychological reliance.

By Jonathan Avery


Adobe

AI doctors should be licensed. Here’s a framework to do that

Just like doctors, autonomous medical AI should demonstrate competency before practicing, through testing, supervised deployment, and ongoing monitoring.

By Alon Bergman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.